Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin in Hypoalbuminemic Patients with CAP
NCT04071041Phase 3Terminated
- Start
- Oct 2019
- Primary completion
- Oct 2021
- Countries
- 1
01
Overview
A Phase 3 trial of albumin (human) in community acquired pneumonia (CAP). Started Oct 2019; status: terminated.
02
Drugs
albumin (human)
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT04071041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04071041.